Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network

NARecruitingINTERVENTIONAL
Enrollment

3,200

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2027

Conditions
SmokingSmoking CessationSecond Hand Tobacco Smoke
Interventions
OTHER

Refer2Quit

The Refer2Quit intervention consists of automatic connection to the adult participant's choice of any or all of four evidence-based tobacco treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), as well as motivational counseling provided by the study team. Supportive and motivational text messaging is also included in the intervention to connect or reconnect adult participants to treatments as needed. Text messaging and support would also focus on supporting appropriate use of NRT and/or varenicline if indicated.

Trial Locations (1)

19146

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Hospital of Philadelphia

OTHER